Simvastatin 80mg

DRUG5 trials

Sponsors

University of Sao Paulo, Helsinki University Central Hospital, Brasilia Heart Study Group, Baylor Breast Care Center, Cambridge University Hospitals NHS Foundation Trust

Conditions

AtherosclerosisBreast Cancer Stage IVCardiovascular DiseasesCoronary Heart DiseaseHeart FailureKidney FailureLiver FailureMyocardial Infarction

Phase 2

Donor Simvastatin Treatment in Organ Transplantation

CompletedNCT01160978

Helsinki University Central HospitalHeart Failure, Kidney Failure, Liver Failure +2

Start: 2010-06-01End: 2016-08-01Updated: 2017-09-19

Simvastatin Plus Dual Anti-HER2 Therapy for Metastatic Breast Cancer

Active, not recruitingNCT03324425

Baylor Breast Care CenterBreast Cancer Stage IV

Start: 2020-03-04End: 2030-12-31Updated: 2025-02-27

Phase 4

Effects of Statin and Ezetimibe Association on Kinetics of Artificial Chilomicrons

CompletedNCT00481351

University of Sao PauloCoronary Heart Disease

Start: 2007-06-30End: 2010-01-31Updated: 2011-01-26

Effect of Statin Treatment on Insulin Sensitivity During Myocardial Infarction

CompletedNCT01205347

Brasilia Heart Study GroupMyocardial Infarction

Start: 2010-10-31End: 2013-09-30Updated: 2013-09-10

Unknown Phase

Investigating the Lowest Threshold of Vascular Benefits From LDL Cholesterol Lowering in Patients With Stable CV Disease

Cambridge University Hospitals NHS Foundation TrustAtherosclerosis, Cardiovascular Diseases

Start: 2017-11-30End: 2023-11-30Updated: 2021-07-23

Related Papers

Investigating the Lowest Threshold of Vascular Benefits from LDL Cholesterol Lowering with a PCSK9 mAb Inhibitor (Alirocumab) in Patients with Stable Cardiovascular Disease (INTENSITY-HIGH): protocol and study rationale for a randomised, open label, parallel group, mechanistic study

BMJ Open2021-04-015 citations

Donor Simvastatin Treatment in Heart Transplantation

Circulation2019-07-2936 citations